Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 SEK | +7.08% |
|
-1.15% | -17.10% |
05-22 | Enorama Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-28 | Intervacc's Acting CEO Assumes Role Permanently | MT |
Business Summary
Number of employees: 5
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Nicotine Gum
100.0
%
| 7 | 100.0 % | 1 | 100.0 % | -80.17% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 7 | 100.0 % | 1 | 100.0 % | -80.17% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Annette Agerskov
CEO | Chief Executive Officer | 64 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 61 | 15-12-31 | |
- | - | ||
Daniel Schroeder
BRD | Director/Board Member | - | - |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 46,150,678 | 16,243,428 ( 35.20 %) | 0 | 35.20 % |
Company contact information
![address Enorama Pharma AB(ERMA)](https://cdn.zonebourse.com/static/address/61747254.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-17.10% | 10.09M | |
+17.07% | 43.26B | |
+17.47% | 21.6B | |
+20.88% | 15.93B | |
+23.93% | 15.1B | |
+56.83% | 12.95B | |
-0.05% | 6.79B | |
-16.22% | 6.29B | |
+19.77% | 6.04B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- ERMA Stock
- Company Enorama Pharma AB